Mobius Medical Systems, LP, the leader in innovative solutions for quality assurance (QA) in radiation oncology, is pleased to announce the release of Mobius3D version 1.5. For users with the MobiusFX treatment verification module, the newest version of Mobius3D automatically verifies accurate delivery of every fraction in a patient’s course of treatment. A new Treatment Summary report displays an interactive analysis of each delivered fraction. If any discrepancies are found, Mobius3D determines the 3D dosimetric impact to the patient.
Nathan Childress Ph.D., founder of Mobius Medical Systems said, “The purpose of creating Mobius3D was to ensure patients receiving radiation would get safe and effective treatments. With the release of version 1.5, clinicians can gain confidence that every fraction is delivered as expected. I am extremely proud of our team for building a product that moves the industry forward by significantly advancing automated radiation oncology QA tools.”
Version 1.5 also adds support for the new Mobius Verification Phantom (MVP). The MVP contains seven ion chamber measurement points and a film plane. Its geometry is built into Mobius3D, allowing QA plans measured using the MVP to be automatically calculated and verified in Mobius3D. The MVP adds flexibility in the Mobius3D ecosystem for commissioning, spot checks, easy investigation into QA failures, and as a secondary IMRT QA device.